P21Cip1 induced by Raf is associated with increased Cdk4 activity in hematopoietic cells

[1]  B. Kempkes,et al.  Cell cycle activation by c‐myc in a Burkitt lymphoma model cell line , 2000, International journal of cancer.

[2]  M. Blagosklonny.  Cell death beyond apoptosis , 2000, Leukemia.

[3]  J. Blenis,et al.  Granulocyte-macrophage colony-stimulating factor stimulation results in phosphorylation of cAMP response element-binding protein through activation of pp90RSK. , 2000, Blood.

[4]  J. McCubrey,et al.  Differential abilities of the Raf family of protein kinases to abrogate cytokine dependency and prevent apoptosis in murine hematopoietic cells by a MEK1-dependent mechanism , 2000, Leukemia.

[5]  C. Der,et al.  Understanding Ras: 'it ain't over 'til it's over'. , 2000, Trends in cell biology.

[6]  J F Barrett,et al.  Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[7]  C. Herrmann,et al.  Mitogenic signaling of Ras is regulated by differential interaction with Raf isozymes , 2000, Oncogene.

[8]  J. McCubrey,et al.  Synergy between Raf and BCL2 in abrogating the cytokine dependency of hematopoietic cells , 2000, Leukemia.

[9]  J. McCubrey,et al.  Serine/threonine phosphorylation in cytokine signal transduction , 2000, Leukemia.

[10]  U. Rapp,et al.  Isotype-specific functions of Raf kinases. , 1999, Experimental cell research.

[11]  O. Bachs,et al.  The Protein SET Regulates the Inhibitory Effect of p21Cip1 on Cyclin E-Cyclin-dependent Kinase 2 Activity* , 1999, The Journal of Biological Chemistry.

[12]  G. Viglietto,et al.  Key role of the cyclin-dependent kinase inhibitor p27kip1 for embryonal carcinoma cell survival and differentiation , 1999, Oncogene.

[13]  K. Kaibuchi,et al.  Ras-induced transformation and signaling pathway. , 1999, Journal of biochemistry.

[14]  E. Calvo,et al.  Expression and modulation of p42/p44 MAPKs and cell cycle regulatory proteins in rat pancreas regeneration. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[15]  F. Beier,et al.  The Raf-1/MEK/ERK Pathway Regulates the Expression of the p21Cip1/Waf1 Gene in Chondrocytes* , 1999, The Journal of Biological Chemistry.

[16]  P. Pandolfi,et al.  Targeted Disruption of CDK4 Delays Cell Cycle Entry with Enhanced p27Kip1 Activity , 1999, Molecular and Cellular Biology.

[17]  M. Nakanishi,et al.  Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein. , 1999, Biochemical and biophysical research communications.

[18]  J. McCubrey,et al.  Signal transduction, cell cycle regulatory, and anti-apoptotic pathways regulated by IL-3 in hematopoietic cells: possible sites for intervention with anti-neoplastic drugs , 1999, Leukemia.

[19]  D. Frank,et al.  STAT Signaling in the Pathogenesis and Treatment of Cancer , 1999, Molecular medicine.

[20]  John M. Sedivy,et al.  c-Myc Regulates Cyclin D-Cdk4 and -Cdk6 Activity but Affects Cell Cycle Progression at Multiple Independent Points , 1999, Molecular and Cellular Biology.

[21]  James M. Roberts,et al.  CDK inhibitors: positive and negative regulators of G1-phase progression. , 1999, Genes & development.

[22]  R. Klemke,et al.  Four Human Ras Homologs Differ in Their Abilities to Activate Raf-1, Induce Transformation, and Stimulate Cell Motility* , 1999, The Journal of Biological Chemistry.

[23]  Mangi Mh,et al.  Interleukin-3 in hematology and oncology: current state of knowledge and future directions. , 1999 .

[24]  M. Ogawa,et al.  Humoral Regulation of Hematopoietic Stem Cells a , 1999, Annals of the New York Academy of Sciences.

[25]  James M. Roberts,et al.  The p21Cip1 and p27Kip1 CDK ‘inhibitors’ are essential activators of cyclin D‐dependent kinases in murine fibroblasts , 1999, The EMBO journal.

[26]  R. Abraham,et al.  A Phosphatidylinositol 3-Kinase-dependent Pathway That Differentially Regulates c-Raf and A-Raf* , 1999, The Journal of Biological Chemistry.

[27]  H. Paterson,et al.  Activation of the Raf/MAP kinase cascade by the Ras‐related protein TC21 is required for the TC21‐mediated transformation of NIH 3T3 cells , 1999, The EMBO journal.

[28]  Angel W. Lee,et al.  Synergistic activation of mitogen-activated protein kinase by cyclic AMP and myeloid growth factors opposes cyclic AMP's growth-inhibitory effects. , 1999, Blood.

[29]  J. McCubrey,et al.  Differential abilities of activated Raf oncoproteins to abrogate cytokine dependency, prevent apoptosis and induce autocrine growth factor synthesis in human hematopoietic cells , 1998, Leukemia.

[30]  R. Schmidt-Ullrich,et al.  The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity , 1998, Leukemia.

[31]  B. Dynlacht,et al.  Activity and nature of p21(WAF1) complexes during the cell cycle. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[32]  U. Rapp,et al.  Cell cycle targets of Ras/Raf signalling , 1998, Oncogene.

[33]  U. Rapp,et al.  Craf-1 protein kinase is essential for mouse development , 1998, Mechanisms of Development.

[34]  J. Manfredi,et al.  Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. , 1998, Genes & development.

[35]  Joseph Avruch,et al.  A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity , 1998, Nature.

[36]  A. Moustakas,et al.  Regulation of the human p21/WAF1/Cip1 promoter in hepatic cells by functional interactions between Sp1 and Smad family members. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Xiao-Fan Wang,et al.  Inhibition of the 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Pathway Induces p53-independent Transcriptional Regulation of p21 WAF1/CIP1 in Human Prostate Carcinoma Cells* , 1998, The Journal of Biological Chemistry.

[38]  D. Johnson,et al.  Regulation of survival pathways by IL-3 and induction of apoptosis following IL-3 withdrawal. , 1998, Frontiers in bioscience : a journal and virtual library.

[39]  J. Troppmair,et al.  Regulation of c-myc expression by Ras/Raf signalling , 1998, Oncogene.

[40]  T. Hirano,et al.  Signal TransductionThrough Cytokine Receptors , 1998 .

[41]  W. Ansorge,et al.  Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes , 1997, Oncogene.

[42]  A. Vartanian,et al.  c‐Raf kinase binds to N‐terminal domain of c‐Myc , 1997, FEBS letters.

[43]  A Sewing,et al.  High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[44]  E. Lees,et al.  Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.

[45]  M. McMahon,et al.  Mutations of critical amino acids affect the biological and biochemical properties of oncogenic A-Raf and Raf-1 , 1997, Oncogene.

[46]  H. Xiao,et al.  Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner. , 1997, Biochemical and biophysical research communications.

[47]  U. Rapp,et al.  Endothelial apoptosis in Braf-deficient mice , 1997, Nature Genetics.

[48]  C. Pritchard,et al.  Raf revealed in life-or-death decisions , 1997, Nature Genetics.

[49]  James M. Roberts,et al.  Cyclin E-CDK2 is a regulator of p27Kip1. , 1997, Genes & development.

[50]  T. Kim.  In vitro transcriptional activation of p21 promoter by p53. , 1997, Biochemical and biophysical research communications.

[51]  H. Yao,et al.  cAMP Activates MAP Kinase and Elk-1 through a B-Raf- and Rap1-Dependent Pathway , 1997, Cell.

[52]  J. LaBaer,et al.  New functional activities for the p21 family of CDK inhibitors. , 1997, Genes & development.

[53]  C. Marshall,et al.  Differential Regulation of Raf-1, A-Raf, and B-Raf by Oncogenic Ras and Tyrosine Kinases* , 1997, The Journal of Biological Chemistry.

[54]  May Ws.  Control of apoptosis by cytokines. , 1997 .

[55]  K. Calame,et al.  Positive and negative regulation of c-Myc transcription. , 1997, Current topics in microbiology and immunology.

[56]  B. Amati,et al.  Growth arrest by the cyclin‐dependent kinase inhibitor p27Kip1 is abrogated by c‐Myc. , 1996, The EMBO journal.

[57]  Anindya Dutta,et al.  Cyclin-binding motifs are essential for the function of p21CIP1 , 1996, Molecular and cellular biology.

[58]  S. Kuroda,et al.  Different Effects of Various Phospholipids on Ki-Ras-, Ha-Ras-, and Rap1B-induced B-Raf Activation* , 1996, The Journal of Biological Chemistry.

[59]  T. Hunter,et al.  Cyclin-dependent Kinases Are Inactivated by a Combination of p21 and Thr-14/Tyr-15 Phosphorylation after UV-induced DNA Damage* , 1996, The Journal of Biological Chemistry.

[60]  C. Pritchard,et al.  Post-natal lethality and neurological and gastrointestinal defects in mice with targeted disruption of the A-Raf protein kinase gene , 1996, Current Biology.

[61]  A. Levine,et al.  Analysis of wild-type and mutant p21WAF-1 gene activities , 1996, Molecular and cellular biology.

[62]  P. Dent,et al.  Ras-induced activation of Raf-1 is dependent on tyrosine phosphorylation , 1996, Molecular and cellular biology.

[63]  M. White,et al.  Ras Interaction with Two Distinct Binding Domains in Raf-1 5 Be Required for Ras Transformation (*) , 1996, The Journal of Biological Chemistry.

[64]  M. Marshall.  Interactions between Ras and Raf: Key regulatory proteins in cellular transformation , 1995, Molecular reproduction and development.

[65]  C. Pritchard,et al.  Conditionally oncogenic forms of the A-Raf and B-Raf protein kinases display different biological and biochemical properties in NIH 3T3 cells , 1995, Molecular and cellular biology.

[66]  P. Beer-Romero,et al.  Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. , 1995, Science.

[67]  C. Marshall,et al.  Ras recruits Raf‐1 to the plasma membrane for activation by tyrosine phosphorylation. , 1995, The EMBO journal.

[68]  F. Ruscetti,et al.  Raf-1 protein is required for growth factor-induced proliferation of hematopoietic cells , 1995, The Journal of experimental medicine.

[69]  J. Massagué,et al.  Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1 , 1995, Nature.

[70]  C. Der,et al.  Two Distinct Raf Domains Mediate Interaction with Ras (*) , 1995, The Journal of Biological Chemistry.

[71]  K. Kinzler,et al.  p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. , 1995, Genes & development.

[72]  S. Elledge,et al.  Inhibition of cyclin-dependent kinases by p21. , 1995, Molecular biology of the cell.

[73]  M. Weber,et al.  Biochemical Analysis of MEK Activation in NIH3T3 Fibroblasts , 1995, The Journal of Biological Chemistry.

[74]  M. Kirschner,et al.  Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA , 1995, Nature.

[75]  J. R. Smith,et al.  Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1. , 1995, The EMBO journal.

[76]  J. Troppmair,et al.  The ins and outs of Raf kinases. , 1994, Trends in biochemical sciences.

[77]  R. Davis,et al.  MAP kinase binds to the NH2‐terminal activation domain of c‐Myc , 1994, FEBS letters.

[78]  W. Fantl,et al.  Activation of Raf-1 by 14-3-3 proteins , 1994, Nature.

[79]  K. Irie,et al.  Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. , 1994, Science.

[80]  F. McCormick,et al.  Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. , 1994, Science.

[81]  G. Hannon,et al.  p21-containing cyclin kinases exist in both active and inactive states. , 1994, Genes & development.

[82]  C. Chuang,et al.  Functional divergence of the MAP kinase pathway ERK1 and ERK2 activate specific transcription factors , 1994, FEBS letters.

[83]  U. Rapp,et al.  The complete sequence and promoter activity of the human A-raf-1 gene (ARAF1). , 1994, Genomics.

[84]  S. Shurtleff,et al.  D-type cyclin-dependent kinase activity in mammalian cells , 1994, Molecular and cellular biology.

[85]  David Beach,et al.  p21 is a universal inhibitor of cyclin kinases , 1993, Nature.

[86]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[87]  D. Morrison,et al.  Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase , 1993, Molecular and cellular biology.

[88]  M. McMahon,et al.  Conditional transformation of cells and rapid activation of the mitogen-activated protein kinase cascade by an estradiol-dependent human raf-1 protein kinase , 1993, Molecular and cellular biology.

[89]  Jonathan A. Cooper,et al.  Mammalian Ras interacts directly with the serine/threonine kinase raf , 1993, Cell.

[90]  T. Pawson,et al.  Mutational activation of c-raf-1 and definition of the minimal transforming sequence , 1990, Molecular and cellular biology.

[91]  V. Stanton,et al.  Definition of the human raf amino-terminal regulatory region by deletion mutagenesis , 1989, Molecular and cellular biology.

[92]  T. Yamamoto,et al.  Molecular cloning and characterization of an activated human c-raf-1 gene. , 1987, Molecular and cellular biology.